• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Significance of postoperative follow-up of patients with metastatic colorectal cancer using circulating tumor DNA

    2019-02-12 12:58:34LucieBeneovTerezalkovRenataPtkovAnastasiyaSemyakinaKateinaMenclovJiPudilMiroslavRyskaMiroslavLevJaromimFilipPazdrekJiHochMilanBlahaMarekMinrik
    World Journal of Gastroenterology 2019年48期

    Lucie Bene?ová, Tereza Hálková, Renata Ptá?ková, Anastasiya Semyakina, Kate?ina Menclová, Ji?í Pudil,Miroslav Ryska, Miroslav Levy, Jaromír ?im?a, Filip Pazdírek, Ji?í Hoch, Milan Blaha, Marek Minárik

    Abstract

    Key words: Circulating tumor DNA; Metastatic colorectal cancer; Postoperative;Radicality of resection; Follow-up; Recurrence

    INTRODUCTION

    Around 50% of patients with colorectal cancer (CRC) are found to have synchronous liver or extrahepatic metastases at the time of diagnosis or will develop metachronous metastases within several years after surgery[1]. It is known that radical surgical resection - the R0 resection which involves a complete removal of the diseased tissue -is the only effective treatment option, ideally in combination with perioperative chemotherapy[2]. The 5-year survival rate for patients with surgical treatment ranges from 41% to over 70% compared to 5% if not treated[3-5].

    Besides removal of metastases, postoperative patient follow-up is no less important as it allows for the timely identification of any progression or recurrence of the disease and prompt therapeutical response - whether by surgery or modification of systematic therapy. The monitoring of patients with metastatic CRC is predominantly based on imaging techniques such as ultrasonography (US), computed tomography(CT), positron emission tomography (PET), magnetic resonance imaging (MRI) or X-ray imaging (XRAY), usually with assessments of serum tumor markers carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9). Nowadays,molecular biology techniques also play an irreplaceable role in the management of patients with CRC, considering that the decisions on cancer therapy are ever more supported by the knowledge of biological characteristics and genetic profile of the disease[6]. Most recently, the possibility for disease follow-up using circulating tumor DNA (ctDNA) has become available in addition to already implemented mutation profiling from tissue biopsies or resecates[7,8].

    The term ctDNA means short fragmented DNA, which has historically been observed in blood circulation of patients suffering with metastatic stages of cancers[9,10]. ctDNA is often referred to as cell-free DNA to emphasize its exogenous nature in comparison to DNA originating from nuclei of the blood cells. Although the exact mechanism of its release into circulation is still subject to debate, there are several probable mechanisms of the ctDNA origin including: Apoptosis; necrosis;active release through lipoproteonucleotidic complexes (virtosomes); phagocytosis;and exocytosis[11]. Due to its exclusive origin in cancerous cells, ctDNA retains the fundamental imprint of its cancer genome including cancer-specific aberrations such as somatic mutations. Therefore, the ctDNA analysis has recently been promoted using the term “l(fā)iquid biopsy”[12]. The main advantage of liquid biopsy, compared to the “classic” biopsy of tumor tissues is its minimal invasiveness and the associated minimal stress for the patient. Additionally, ctDNA is released to the bloodstream from all tumor foci, and thus a single blood sample contains the complete mutation spectrum of cancer clones present in the patient's body[13].

    Besides liquid biopsy, ctDNA testing has proven to be a very promising instrument for long-term, postoperative follow-ups of patients with CRC, particularly in advanced stages. Being minimally invasive, it can be repeated over short periods for a long time with no significant burden to the patient, and moreover, this test shows high sensitivity and specificity to patients with preoperative ctDNA positivity[14]. The approach fundamentally relies on the applied methodology, which must be able to capture < 0.1% of ctDNA on the background of non-tumor DNA. Accordingly, the current techniques include dedicated approaches such as those based on digital PCR,BEAMing or deep sequencing[15]. In all cases, tumor-specific DNA alterations (usually mutations) found in the tumor tissue or occurring with a certain significant frequency in the given cancer are used as ctDNA positivity markers. However, the above mentioned methods have their limitations, particularly in terms of higher demands on the input DNA amount and the costs. Another sensitive, efficient, rapid and affordable method based on the formation of heteroduplexes with subsequent detection using denaturing capillary electrophoresis (DCE) has been used at our center for 10 years. This method can be used to detect a mutated locus in plasma with the sensitivity of 0.03% to 1% depending on the mutation to be determined (Table 1)with input DNA amount of tens of pg[16,17]. The specificity of this ctDNA test is 100%,which means that the presence of ctDNA always provides evidence that a tumor residue or tumor cells are present. As previously shown by us, ctDNA testing using DCE allows patient follow-up in real time, while ctDNA levels correlate very well with the current condition of the patient[17]. As we reported in this paper about a group of patients with metastatic CRC, ctDNA can be used in clinical practice,particularly for the evaluation of the radicality of surgery and for the timely detection of any progression or recurrence of the disease.

    MATERIALS AND METHODS

    Patients and samples

    This study was conducted in cooperation with three prime surgery centers in the Czech Republic in accordance with the Declaration of Helsinki and was approved by ethics committees of the relevant hospitals. The forty-seven patients enrolled in the study had undergone the resection of synchronous or metachronous colorectal cancer metastases and tested positive for ctDNA before surgery, and were thus suitable candidates for postoperative ctDNA follow-up. Patient characteristics are listed in Table 2. All patients signed an informed consent form for the study. A tumor tissue sample was surgically obtained in each case. Peripheral blood samples for ctDNA analysis were collected in an anticoagulant solution before, 1 week after the surgery,and subsequently in several-month intervals during their follow-ups. Clinical patient data including tumor localization and type, surgical radicality, and CEA and CA 19-9 marker levels were also collected.

    Table 1 Characteristics of the markers used for the mutation analysis[16,17]

    DNA isolation and detection of mutations

    Mutation profiles were determined in DNA isolated from tumor tissues,subsequently, the detected mutations were analyzed in plasma samples. Tumor DNA was isolated from the samples of native frozen (-20 °C) tissues using the GenElute?Mammalian Genomic DNA Miniprep Kit (Sigma Aldrich, St. Louis, MS, United States). ctDNA was isolated using the NucleoSpin Plasma XS (Macherey-Nagel,Dueren, Germany) from plasma according to the instructions of the manufacturer.Plasma was obtained by centrifugation of blood promptly after collection, and then immediately frozen at -20 °C. The mutations were identified using a panel for the detection of the most commonly mutated loci in theKRAS,TP53,APC,PIK3CA,BRAFandCTNNB1genes, which are characteristic for colorectal cancer (see Table 1 for details). Tumor tissue and ctDNA mutations were detected using PCR with the formation of heteroduplexes and subsequent separation using DCE. The principle of the method has been described previously[18].

    Resection radicality and recurrence of the disease

    The radicality of surgical removal of colorectal cancer metastases was determined by the pathologist based on examination of the resected samples' margins. Complete resections with no macroscopic or microscopic tumor residues were identified as R0.For R0 resections, the minimum distance of tumor cells from the resection line was > 0 mm. Microscopically incomplete resections, with a presence of tumor cells in the margin detected by the pathologist, were identified as R1. Macroscopically incomplete resections were identified as R2 and were classified as R2a (macroscopic presence of a residue of the primary tumor), R2b (macroscopic presence of distal metastases), R2c(macroscopic presence of any residue(s) of the primary tumor as well as of distal metastases)[19]. The surgical radicality assessments were supplemented with an analysis of postoperative ctDNA.

    Disease recurrence was longitudinally monitored and was assessed using imaging methods (most commonly CT, MRI, US, XRAY) and using CEA (normal levels ≤ 5 ng/mL) and CA19-9 (normal levels ≤ 37 U/mL) tumor marker levels. Any abnormalities detected by imaging techniques or elevated levels of at least one tumor marker were considered recurrences. This data were correlated with the presence of ctDNA. The ctDNA was evaluated until recurrence or during the patient's follow-up period.

    Table 2 Clinical patient data

    RESULTS

    Detailed information on the 47 patients enrolled in the study is available in Supplementary Table 1. In total, 79 tumor tissue samples (25 from the primary tumor, 6 from lymph nodes and 48 from distal metastases) and 202 plasma samples (51 before surgery, 39 after surgery and 112 during follow-up) were collected over the course of the study. A detailed overview of the collected samples and mutations detected in tumor tissue is provided in Supplementary Table 2.

    Sixty-three resections were done during the study (including repeated resections during follow-up), which comprised 40 R0, 7 R1 and 16 R2 resections. A postoperative ctDNA sample to assess the correlation of ctDNA and surgery radicality was available for 39 patients undergoing 50 surgeries (28 R0, 7 R1 and 15 R2) (Table 3; for detailed information see Supplementary Table 1). Among the 28 cases of R0 resection,postoperative ctDNA tested negative in 26 cases (26/28, 93%). After the first of the two remaining R0 surgeries, a RFA of a small metastasis in the liver, the patient continued displaying ctDNA and, subsequently, was diagnosed with disease recurrence within the scar 6 mo after the surgery. The second case of ctDNA positivity after R0 surgery was a right-sided hemicolectomy with metastasectomy. Also, in this case, the recurrence (two new liver metastases) was visibleviaimaging methods 6 months after the surgery.

    In 7 cases with R1 resection, postoperative ctDNA was positive 4 times (4/7, 57%)with disease recurrence 3, 3, 4 and 7 mo after surgery in these cases. For the remaining 3 patients with negative ctDNA after R1 surgery (3/7, 43%), two of them had postoperative recurrence after 7 or 22 mo, and the third one has gone 5 months with no recurrence after surgery. Postoperative ctDNA was positive in all 15 patients with R2 resection (15/15, 100%).

    Postoperative tumor recurrence was evaluated according to positive results of ctDNA testing, imaging methods and tumor marker assessments. In our set of 32patients undergoing R0 resections of liver metastases and long-term postoperative monitoring, 22 patients had recurrences (22/32, 69%, see Supplementary Table 1). In 17 patients, from whom all parameters for the detection of postoperative tumor recurrence were available, a total of 22 recurrences were confirmed (3 patients had repeated recurrences - 2 and 4 recurrences). Thirteen times (13/22, 59%) the recurrence was simultaneously detected by ctDNA, imaging methods and tumor markers. Seven times (7/22, 32%) the tumor markers were negative and 6 times (6/22,27%) the imaging methods were without evidence of tumor. The ctDNA was not negative even once (0/22, 0%), making ctDNA in our study the most sensitive tool for detecting tumor recurrence of all three methods. In four patients (4/22, 18%) the tumor recurrence was detected by ctDNA only, while imaging methods and tumor markers were negative (Table 4).

    Table 3 Correlation of surgical radicality and postoperative circulating tumor DNA

    DISCUSSION

    Radicality of surgery is normally assessed based on histological examination of a resected sample and based on the results of imaging methods. However, these examinations cannot indicate any potential presence of circulating tumor cells found in the bloodstream or lymphatic pathways due to a metastatic process or dissemination during surgery. Potential presence of microscopic metastases cannot be demonstrated using histology or imaging methods either. Although the follow-up of tumor marker levels may be useful for detection, their sensitivity and specificity are low[20]. ctDNA is a highly dynamic marker with an approximate half-life of 2 hours,and its levels correspond to the clinical condition of patients with mCRC[17,21]. As we have shown in this paper, a postoperative presence of ctDNA correlates very well with surgery radicality, and its elevated levels in R0 and R1 resections may signal the occurrence of micrometastases and thus help to identify patients with an increased risk of early recurrence for a higher frequency of their follow-up assessments or for an indication of adjuvant therapy[22-24].

    To date, only three papers have been published studying the presence of ctDNA immediately after CRC resection. One study in 2005 focused onKRASmutation persistence in the plasma of patients with colorectal cancer in various stages 3 days from radical surgery. As surprisingly indicated by the results, most patients with preoperatively detectedKRASmutations in plasma had the same mutations detected in plasma, also 3 days from radical surgery (7/9, 78%). Only two patients had no mutation detected in the postoperative period (2/9, 22%)[25]. As mentioned in another study, ctDNA can provide information on radicality of primary resection of colorectal cancer, which was illustrated in the case of a patient where evidence of insufficient radicality of the primary surgery was provided based on the presence of postoperative ctDNA[26]. The last study from 2016 showed a correlation between R0 resections and postoperative ctDNA negativity in 75% of patients (6/8) and a correlation between R2 resection and postoperative ctDNA positivity in 67% of patients (2/3), by presenting a set of 11 patients with preoperatively positive ctDNA results, undergoing R0 (8 times) or R2 (3 times) resection[27].

    Compared to the above mentioned studies, our study presents the largest group of patients so far with preoperatively detected ctDNA (47 in total) in whom postoperative ctDNA correlation with surgery radicality was followed, and this studyis also the first to report ctDNA correlation with R1 resection. In our group of patients who underwent R1 resections, more than half of them were postoperative ctDNA positive. Considering that in these patients, only a small number of tumor cells were present in the resection margin that they are unlikely to release their DNA into the bloodstream, ctDNA positivity could indicate that there are still other micrometastases not detected by imaging methods. This corresponds to significantly shorter times without recurrence (3, 3, 4 and 7 mo) compared to patients with negative postoperative ctDNA (7 and 22 mo). The presence of micrometastases was also probably recognized in two postoperative ctDNA-positive patients undergoing R0 resection, as their time to recurrence was also very short (6 mo both) when compared to patients with negative R0 postoperative ctDNA (14 times recurrence after 4-22 mo, 10 times no recurrence in surveillance 6-36 mo). Unlike other studies,postoperative ctDNA positivity was captured in all R2 resections (15/15, 100%) in our study, which may be due to the sensitivity of the used detection methods. Our DCE method provides the limit of detection (LOD) of 0.03%-1% (see Table 1), while the studies referred to above used the Temperature Gradient Gel Electrophoresis method with LOD 1%-5%[28]and the Quantitative Polymerase Chain Reaction assay based on allele-specific PCR with LOD 1%-2%[29].

    Table 4 Comparison of circulating tumor DNA and standard detection methods

    Liver metastatic recurrence occurs in approximately 50% of patients undergoing hepatectomy, while 12% have a recurrence more than once. Considering that repeated hepatectomy combined with systemic therapy may improve overall survival of these patients[30-32], efficient follow-ups for the early detection of recurrence is very important[33].

    Tumor markers are commonly used for follow-ups, but so far cannot be used alone to diagnose recurrence, and imaging methods sometimes do not recognize small foci(micrometastases) or, on the contrary, find abnormalities that are not cancer.Examination of ctDNA could be another tool used during follow-up. Our detection method enables high reliability testing (the false positive probability of ctDNA is 0%).In our 22 cases of postoperative tumor recurrence imaging methods and tumor marker results detected a recurrence in 16/22 (73%) and 15/22 (68%) cases,respectively, ctDNA was present in 22/22 (100%) cases. Our results are consistent with the findings of several similar studies that have been performed on a comparable or smaller number of samples[24,26,34-36]. Therefore, we consider our set of 22 recurrences after curative (R0) surgical treatment recorded in our study as adequate to confirm utility of the ctDNA test as a viable tool for the early detection of mCRC recurrence.

    Compared to our overall ctDNA detection rate in patients with advanced CRC at the time of the diagnosis (55%-75%), the detection rate in patients previously tested positive for ctDNA is much higher. This data indicates that although the ctDNA release rate into the bloodstream due to the presence of tumor foci differs in various patients with mCRC, for each given patient this phenomenon is relatively stable; thus if ctDNA is detectable in the body when tumor foci are present, it is highly probable that after their complete removal and subsequent recurrence, ctDNA will be detected again.

    Although ctDNA detection cannot replace traditional methods used in the followup scheme, it might be a useful supplementary instrument for both the prediction and earlier detection of recurrences, particularly in patients with a higher risk of liver metastatic recurrence[37], and thus it may actually improve the overall survival odds of such patients.

    ARTICLE HIGHLIGHTS

    extrahepatic metastases at the time of diagnosis, or will develop metachronous metastases within several years after surgery. It is known that radical surgical resection, the R0 resection which involves a complete removal of the diseased tissue, is the only effective treatment option, ideally in combination with perioperative chemotherapy. Besides removal of colorectal cancer metastases, postoperative patient follow-up is no less important as it allows for the timely identification of any progression or recurrence of the disease and prompt therapeutical response.The monitoring of patients is predominantly based on imaging techniques, usually with assessments of serum tumor markers. One of the promising tools for long-term postoperative follow-up is the detection of circulating tumor DNA (ctDNA) in the peripheral blood. Sometimes referred to as a "liquid (re)biopsy" it is a minimally invasive procedure and can be performed repeatedly at relatively short intervals (months or even weeks). The presence of the disease and the actual extent of the tumor burden (tumor mass) within the patient's body can be monitored.This is of particular importance, especially when evaluating radicality of surgical treatment as well as for early detection of disease progression or recurrence.

    Research motivation

    Radicality of surgery is normally assessed using histological examination of a resected sample and based on the results of imaging methods. However, these examinations cannot indicate any potential presence of circulating tumor cells or microscopic metastases. Also, the main tools used for postoperative patient follow-up, imaging methods and tumor markers, are often not sufficient in early detection of disease progression or recurrence. Tumor markers have low specificity and sensitivity so that they cannot be used alone to diagnose recurrence. Imaging methods are known to fail to detect small foci (micrometastases) or, on the contrary, find abnormalities that are not cancer. Moreover, they cannot be performed frequently due to the radiation exposure. The recently introduced ctDNA testing could present a useful alternative tool. It has proven to be very promising for long-term, postoperative follow-ups of patients with CRC, particularly in advanced stages. Being minimally invasive, it can be repeated frequently for a long time with no significant burden to the patient, and moreover, this test shows high sensitivity and specificity to patients with preoperative ctDNA positivity.

    Research objectives

    The main objectives of the study were to confirm the radicality of surgery using ctDNA and to compare available methods for detection of recurrence in metastatic CRC (mCRC). It is important to verify whether ctDNA can be used in clinical practice, particularly for the evaluation of the radicality of surgery and for the timely detection of any progression or recurrence of the disease.

    Research methods

    A total of 47 patients with detected ctDNA and indications for resection of mCRC were enrolled in the multicenter study involving three surgical centers. Standard postoperative follow-ups using imaging techniques and the determination of tumor markers were supplemented by ctDNA sampling. In addition to the baseline ctDNA testing prior to surgery, a postoperative observation was conducted by evaluating ctDNA presence up to a week after surgery and subsequently at approximately three-month intervals. The presence of ctDNA was correlated with radicality of surgical treatment and the actual clinical status of the patient. To test ctDNA,we performed a sensitive, efficient, rapid and affordable method based on the formation of heteroduplexes with subsequent detection using denaturing capillary electrophoresis (DCE).This method can be used to detect a mutated locus in plasma with the sensitivity of 0.03% to 1%depending on the mutation to be determined with input DNA amount of tens of pg. The specificity of this ctDNA test is 100%, which means that the presence of ctDNA always provides evidence that a tumor residue or tumor cells are present. As previously shown by us, ctDNA testing using DCE allows a patient follow-up in real time, while ctDNA levels correlate very well with the current condition of the patient.

    Research results

    Among the monitored patients, the R0 (curative) resection correlated with postoperative ctDNA negativity in 26 out of 28 cases of surgical procedures (93%). In the remaining cases of R0 surgeries that displayed ctDNA, both patients were diagnosed with a recurrence of the disease after 6 mo. In 7 patients who underwent an R1 resection, 4 ctDNA positivities (57%) were detected after surgery and associated with the confirmation of early disease recurrence (after 3-7 mo). All 15 patients undergoing R2 resection remained constantly ctDNA positive during the entire follow-up period. In 22 cases of recurrence, ctDNA positivity was detected 22 times (100%)compared to 16 positives (73%) by imaging methods and 15 cases (68%) of elevated tumor markers.

    Research conclusions

    Although ctDNA detection cannot replace traditional methods used in the follow-up scheme, it might represent a useful supplementary instrument for both the prediction and earlier detection of recurrences, particularly in patients with a higher risk of liver metastatic recurrence, and thus it may actually improve the overall survival odds of such patients. And it has also been shown that the ctDNA test is a highly specific and sensitive tool for confirming the radicality of surgical treatment and for the potential prediction of early disease recurrence after R0/R1 surgeries.

    Research perspectives

    In this study, the high sensitivity of the methodology used to test ctDNA after curative mCRC surgical treatment and also to detect recurrence of the disease was shown. However, to confirm this hypothesis, testing on a larger sample set is required. In particular, it is desirable to obtain a greater number of ctDNA positive and negative results after R1 resections that could be correlated with time to disease recurrence. Similarly, expanding the set of long-term follow-up patients using standard approaches supplemented with ctDNA sampling is warranted.

    只有这里有精品99| 9色porny在线观看| 亚洲欧美一区二区三区国产| 内地一区二区视频在线| 国产黄片美女视频| 26uuu在线亚洲综合色| 亚洲欧洲精品一区二区精品久久久 | 国产亚洲5aaaaa淫片| 久久久久视频综合| 99久国产av精品国产电影| 国产精品蜜桃在线观看| 国产av一区二区精品久久| 三级国产精品欧美在线观看| 欧美精品国产亚洲| 男人爽女人下面视频在线观看| 97在线人人人人妻| 人体艺术视频欧美日本| 一本—道久久a久久精品蜜桃钙片| 黄色毛片三级朝国网站 | 国产精品国产三级专区第一集| 亚洲av福利一区| 一本久久精品| 国产日韩欧美在线精品| 亚洲第一区二区三区不卡| 亚洲精品日韩av片在线观看| 久久久久久久精品精品| 欧美xxxx性猛交bbbb| 男人添女人高潮全过程视频| 免费观看av网站的网址| 国产男人的电影天堂91| 精品人妻熟女av久视频| 国产成人午夜福利电影在线观看| 欧美亚洲 丝袜 人妻 在线| 爱豆传媒免费全集在线观看| 老司机亚洲免费影院| 国产日韩欧美亚洲二区| 肉色欧美久久久久久久蜜桃| 自拍欧美九色日韩亚洲蝌蚪91 | 男女啪啪激烈高潮av片| 搡老乐熟女国产| 下体分泌物呈黄色| 国产色婷婷99| av网站免费在线观看视频| 日韩中文字幕视频在线看片| 中文乱码字字幕精品一区二区三区| 老女人水多毛片| 国产精品一区二区在线观看99| 欧美三级亚洲精品| 草草在线视频免费看| 久久ye,这里只有精品| 国产老妇伦熟女老妇高清| 老司机影院成人| 久久精品国产a三级三级三级| 91成人精品电影| 国产精品99久久久久久久久| 最黄视频免费看| 视频中文字幕在线观看| 欧美3d第一页| av有码第一页| 美女主播在线视频| 嫩草影院入口| 国产在线一区二区三区精| 成人免费观看视频高清| 国产成人91sexporn| 亚洲,一卡二卡三卡| 一级av片app| 尾随美女入室| av免费观看日本| 久久久久久久精品精品| 久久精品国产a三级三级三级| 三级经典国产精品| 色婷婷av一区二区三区视频| 国内精品宾馆在线| a级一级毛片免费在线观看| 人妻夜夜爽99麻豆av| 国产一区亚洲一区在线观看| 国产在视频线精品| 在线观看免费视频网站a站| 人妻夜夜爽99麻豆av| 日韩av免费高清视频| 国产精品嫩草影院av在线观看| 精品亚洲成国产av| 麻豆成人午夜福利视频| 国产成人精品一,二区| 欧美三级亚洲精品| 男女边吃奶边做爰视频| 丰满饥渴人妻一区二区三| 尾随美女入室| 国产精品秋霞免费鲁丝片| 午夜福利视频精品| 亚洲国产精品国产精品| 两个人的视频大全免费| 国国产精品蜜臀av免费| 韩国av在线不卡| 欧美高清成人免费视频www| 欧美亚洲 丝袜 人妻 在线| 9色porny在线观看| 久久精品国产a三级三级三级| 欧美区成人在线视频| 一级毛片 在线播放| 国语对白做爰xxxⅹ性视频网站| 精品人妻一区二区三区麻豆| 男的添女的下面高潮视频| 国产精品欧美亚洲77777| 乱系列少妇在线播放| 国产成人午夜福利电影在线观看| 久久精品久久久久久噜噜老黄| av卡一久久| 亚洲av在线观看美女高潮| 久久国产精品大桥未久av | 特大巨黑吊av在线直播| 日本免费在线观看一区| av一本久久久久| 97精品久久久久久久久久精品| 国产成人午夜福利电影在线观看| 日日爽夜夜爽网站| av黄色大香蕉| 欧美精品人与动牲交sv欧美| 偷拍熟女少妇极品色| 啦啦啦啦在线视频资源| 性高湖久久久久久久久免费观看| 色吧在线观看| 少妇人妻精品综合一区二区| 亚洲国产精品999| 婷婷色麻豆天堂久久| 亚洲av电影在线观看一区二区三区| 久久精品久久久久久久性| 精品人妻熟女毛片av久久网站| 日韩中字成人| 2021少妇久久久久久久久久久| 男人添女人高潮全过程视频| 亚洲天堂av无毛| 国产成人免费无遮挡视频| 久久精品国产a三级三级三级| 日本免费在线观看一区| 久久午夜综合久久蜜桃| 国产精品蜜桃在线观看| 男女免费视频国产| 偷拍熟女少妇极品色| 午夜精品国产一区二区电影| 欧美日韩一区二区视频在线观看视频在线| 在线观看国产h片| 一级av片app| 亚洲av二区三区四区| 成人国产av品久久久| 青春草国产在线视频| 精品少妇黑人巨大在线播放| 亚洲精品乱久久久久久| 午夜激情福利司机影院| 国产精品99久久久久久久久| 日韩三级伦理在线观看| 天堂俺去俺来也www色官网| 看免费成人av毛片| 又粗又硬又长又爽又黄的视频| 少妇人妻精品综合一区二区| 欧美激情极品国产一区二区三区 | 亚洲天堂av无毛| 国精品久久久久久国模美| 十八禁高潮呻吟视频 | 国产精品久久久久久精品古装| av有码第一页| 国产男人的电影天堂91| 18禁动态无遮挡网站| 国产男女超爽视频在线观看| 男女国产视频网站| 久久久久久久久久久丰满| 纵有疾风起免费观看全集完整版| 狂野欧美激情性xxxx在线观看| 香蕉精品网在线| av天堂中文字幕网| 丰满乱子伦码专区| 十八禁高潮呻吟视频 | 国产91av在线免费观看| 在线观看av片永久免费下载| 卡戴珊不雅视频在线播放| 久久久国产欧美日韩av| av在线观看视频网站免费| 日日爽夜夜爽网站| 国产精品国产av在线观看| 亚洲精品日韩av片在线观看| 99久久精品国产国产毛片| 欧美变态另类bdsm刘玥| 七月丁香在线播放| 建设人人有责人人尽责人人享有的| 五月开心婷婷网| 又粗又硬又长又爽又黄的视频| 欧美丝袜亚洲另类| 美女脱内裤让男人舔精品视频| 97在线视频观看| 国产一级毛片在线| 成人毛片60女人毛片免费| 亚洲国产精品一区三区| 免费黄频网站在线观看国产| 亚洲天堂av无毛| 我要看黄色一级片免费的| 91精品一卡2卡3卡4卡| 久久精品久久久久久噜噜老黄| 男人和女人高潮做爰伦理| 亚洲欧美成人精品一区二区| 日韩三级伦理在线观看| 欧美丝袜亚洲另类| 精品人妻偷拍中文字幕| 好男人视频免费观看在线| 国产av一区二区精品久久| 久久精品国产自在天天线| 国产精品嫩草影院av在线观看| 人人妻人人爽人人添夜夜欢视频 | 狠狠精品人妻久久久久久综合| 永久网站在线| 热re99久久国产66热| 日韩精品免费视频一区二区三区 | 久久鲁丝午夜福利片| 我的女老师完整版在线观看| 在线观看www视频免费| 久久国产精品大桥未久av | 人人妻人人澡人人爽人人夜夜| 国国产精品蜜臀av免费| 国产一区有黄有色的免费视频| 日日啪夜夜撸| 五月天丁香电影| 免费看光身美女| 亚洲av福利一区| 中文字幕亚洲精品专区| 最新的欧美精品一区二区| 午夜老司机福利剧场| 日韩在线高清观看一区二区三区| 在线观看三级黄色| 亚洲国产成人一精品久久久| 欧美亚洲 丝袜 人妻 在线| 亚洲综合精品二区| www.av在线官网国产| 国产国拍精品亚洲av在线观看| 欧美 日韩 精品 国产| 边亲边吃奶的免费视频| 国模一区二区三区四区视频| 不卡视频在线观看欧美| 亚洲欧洲精品一区二区精品久久久 | 99热全是精品| 午夜福利在线观看免费完整高清在| 偷拍熟女少妇极品色| 啦啦啦啦在线视频资源| 欧美日韩一区二区视频在线观看视频在线| 男男h啪啪无遮挡| 久久久精品免费免费高清| 国产极品粉嫩免费观看在线 | 中文字幕亚洲精品专区| 亚洲欧美精品专区久久| 国产成人aa在线观看| 色网站视频免费| 中国国产av一级| 免费黄频网站在线观看国产| 极品人妻少妇av视频| 青春草国产在线视频| 精品熟女少妇av免费看| 欧美日韩国产mv在线观看视频| 中文资源天堂在线| 国国产精品蜜臀av免费| 国产淫语在线视频| 一本色道久久久久久精品综合| 丝袜在线中文字幕| 国产极品天堂在线| 亚洲欧美一区二区三区国产| 两个人的视频大全免费| 国产亚洲精品久久久com| 精品酒店卫生间| 男女国产视频网站| 人妻 亚洲 视频| 久久久久久伊人网av| 久久精品久久久久久久性| 天天操日日干夜夜撸| av国产久精品久网站免费入址| 欧美+日韩+精品| 国产亚洲欧美精品永久| 国产色爽女视频免费观看| 69精品国产乱码久久久| 人妻系列 视频| 寂寞人妻少妇视频99o| 午夜福利视频精品| 国产成人精品福利久久| 精品少妇久久久久久888优播| 午夜免费观看性视频| 桃花免费在线播放| 久久精品国产a三级三级三级| 日本av免费视频播放| 下体分泌物呈黄色| 伦理电影大哥的女人| 亚洲情色 制服丝袜| 美女中出高潮动态图| 少妇人妻久久综合中文| 99热这里只有精品一区| 精品熟女少妇av免费看| 青春草亚洲视频在线观看| 免费看日本二区| 九九在线视频观看精品| av免费在线看不卡| 老司机亚洲免费影院| 久久久欧美国产精品| 婷婷色综合大香蕉| videossex国产| 久热这里只有精品99| 深夜a级毛片| 好男人视频免费观看在线| 亚洲丝袜综合中文字幕| freevideosex欧美| 少妇猛男粗大的猛烈进出视频| 国产高清三级在线| 男女啪啪激烈高潮av片| 国产av国产精品国产| 久久久a久久爽久久v久久| 亚洲精品自拍成人| 一二三四中文在线观看免费高清| 久久久国产欧美日韩av| 午夜日本视频在线| 久久 成人 亚洲| a级片在线免费高清观看视频| 大码成人一级视频| 欧美精品高潮呻吟av久久| 一区二区av电影网| 乱人伦中国视频| av福利片在线| 在线亚洲精品国产二区图片欧美 | 天堂8中文在线网| 国产av一区二区精品久久| 日韩大片免费观看网站| 丁香六月天网| 26uuu在线亚洲综合色| 美女cb高潮喷水在线观看| 在线精品无人区一区二区三| 国产精品女同一区二区软件| 另类亚洲欧美激情| av天堂久久9| 蜜桃久久精品国产亚洲av| 成人亚洲欧美一区二区av| av国产精品久久久久影院| 丝袜喷水一区| 国产精品无大码| 亚洲欧美日韩另类电影网站| 蜜臀久久99精品久久宅男| 最近的中文字幕免费完整| 久久99一区二区三区| 国内精品宾馆在线| 高清黄色对白视频在线免费看 | 只有这里有精品99| 欧美丝袜亚洲另类| 日本午夜av视频| 亚洲精品中文字幕在线视频 | 国产 精品1| 人妻夜夜爽99麻豆av| 99久久精品国产国产毛片| 美女脱内裤让男人舔精品视频| 国产免费一区二区三区四区乱码| 成人亚洲欧美一区二区av| 99久久综合免费| 国产成人精品福利久久| 国产精品久久久久久av不卡| 人人妻人人澡人人爽人人夜夜| 少妇猛男粗大的猛烈进出视频| 成年人免费黄色播放视频 | a级一级毛片免费在线观看| 国产国拍精品亚洲av在线观看| 欧美97在线视频| 自拍欧美九色日韩亚洲蝌蚪91 | 欧美日韩视频高清一区二区三区二| 国产精品不卡视频一区二区| 观看美女的网站| 人人妻人人爽人人添夜夜欢视频 | 国产欧美日韩精品一区二区| 免费av中文字幕在线| 久热这里只有精品99| 国产亚洲午夜精品一区二区久久| 久热这里只有精品99| 夫妻午夜视频| 久久亚洲国产成人精品v| 成人18禁高潮啪啪吃奶动态图 | 亚洲成色77777| 91久久精品国产一区二区成人| 免费看光身美女| 国产黄片视频在线免费观看| 女性生殖器流出的白浆| 日韩欧美精品免费久久| 亚洲av日韩在线播放| 久久久久网色| 日韩av在线免费看完整版不卡| 久久精品夜色国产| 黄片无遮挡物在线观看| 极品教师在线视频| 日韩精品有码人妻一区| 精品亚洲乱码少妇综合久久| 日韩中文字幕视频在线看片| h视频一区二区三区| 九色成人免费人妻av| 久久狼人影院| 伦理电影免费视频| 在线精品无人区一区二区三| 在线观看免费高清a一片| 久久久国产精品麻豆| 日日爽夜夜爽网站| 人体艺术视频欧美日本| 成年人午夜在线观看视频| 日本黄大片高清| 国产片特级美女逼逼视频| 中文天堂在线官网| 国产视频内射| 69精品国产乱码久久久| 国产乱人偷精品视频| 七月丁香在线播放| 久久狼人影院| 一级二级三级毛片免费看| 欧美激情国产日韩精品一区| 毛片一级片免费看久久久久| 日本-黄色视频高清免费观看| 老司机亚洲免费影院| av网站免费在线观看视频| 免费黄色在线免费观看| 日本色播在线视频| 熟妇人妻不卡中文字幕| 亚洲av.av天堂| 久久久久久久亚洲中文字幕| 午夜久久久在线观看| 国产又色又爽无遮挡免| 亚洲av电影在线观看一区二区三区| 欧美+日韩+精品| 免费观看无遮挡的男女| 色网站视频免费| 国产精品熟女久久久久浪| 天天躁夜夜躁狠狠久久av| 麻豆精品久久久久久蜜桃| 只有这里有精品99| 中文字幕免费在线视频6| 亚洲国产精品专区欧美| 日本欧美视频一区| 亚洲精品国产成人久久av| 中国美白少妇内射xxxbb| 啦啦啦中文免费视频观看日本| 亚洲av二区三区四区| 一本大道久久a久久精品| 欧美精品一区二区大全| 免费看av在线观看网站| 国产精品秋霞免费鲁丝片| 男的添女的下面高潮视频| 少妇 在线观看| 国产真实伦视频高清在线观看| 精品99又大又爽又粗少妇毛片| 亚洲av.av天堂| 中文字幕久久专区| 在线观看国产h片| 免费大片黄手机在线观看| 亚洲高清免费不卡视频| 看非洲黑人一级黄片| 最近2019中文字幕mv第一页| 久久国产乱子免费精品| 日日啪夜夜爽| 亚洲欧洲日产国产| 99国产精品免费福利视频| 91精品伊人久久大香线蕉| 夫妻性生交免费视频一级片| 亚洲国产精品成人久久小说| 91aial.com中文字幕在线观看| 成年av动漫网址| av免费在线看不卡| 少妇的逼水好多| 亚洲精品久久午夜乱码| 高清午夜精品一区二区三区| 水蜜桃什么品种好| 国产真实伦视频高清在线观看| 亚洲图色成人| 一边亲一边摸免费视频| 99国产精品免费福利视频| 日本黄色日本黄色录像| 在线观看国产h片| 又爽又黄a免费视频| 99国产精品免费福利视频| 国产极品粉嫩免费观看在线 | av免费在线看不卡| 丝瓜视频免费看黄片| av福利片在线| 欧美 日韩 精品 国产| 免费高清在线观看视频在线观看| 亚洲欧美日韩另类电影网站| 亚洲激情五月婷婷啪啪| 久久人人爽人人片av| 国产精品无大码| 国产精品蜜桃在线观看| 免费观看a级毛片全部| 超碰97精品在线观看| 亚洲精品视频女| 麻豆成人午夜福利视频| 日本-黄色视频高清免费观看| 国产免费一区二区三区四区乱码| 女人久久www免费人成看片| 久久99热这里只频精品6学生| 在线播放无遮挡| 搡老乐熟女国产| 18+在线观看网站| 午夜久久久在线观看| 午夜免费观看性视频| 一级a做视频免费观看| av专区在线播放| 一级片'在线观看视频| 又黄又爽又刺激的免费视频.| 日韩大片免费观看网站| 丝袜喷水一区| 日韩大片免费观看网站| 观看免费一级毛片| 我的女老师完整版在线观看| 中文在线观看免费www的网站| 少妇人妻久久综合中文| 又爽又黄a免费视频| 亚洲av男天堂| 精品亚洲成国产av| 美女国产视频在线观看| 乱码一卡2卡4卡精品| 亚洲av.av天堂| 观看免费一级毛片| 最近最新中文字幕免费大全7| 亚洲美女搞黄在线观看| 亚洲国产av新网站| 国产高清三级在线| 国产综合精华液| 精品国产一区二区三区久久久樱花| 97精品久久久久久久久久精品| 亚洲欧洲国产日韩| 亚洲丝袜综合中文字幕| 久久 成人 亚洲| 亚洲精品aⅴ在线观看| 91精品国产九色| 一本色道久久久久久精品综合| 国产伦理片在线播放av一区| 一区二区三区乱码不卡18| 国产黄色免费在线视频| 日日啪夜夜爽| 亚洲国产精品一区三区| 一级毛片黄色毛片免费观看视频| 少妇熟女欧美另类| 美女国产视频在线观看| 日日摸夜夜添夜夜添av毛片| 婷婷色综合www| av播播在线观看一区| 一个人免费看片子| 免费大片18禁| 日本免费在线观看一区| 婷婷色av中文字幕| 在线观看三级黄色| 人妻制服诱惑在线中文字幕| 下体分泌物呈黄色| 亚洲欧美成人综合另类久久久| 久久婷婷青草| 热re99久久国产66热| 91午夜精品亚洲一区二区三区| 老熟女久久久| 国产日韩一区二区三区精品不卡 | 午夜福利网站1000一区二区三区| 特大巨黑吊av在线直播| 色哟哟·www| 三级经典国产精品| 99热6这里只有精品| 亚洲av.av天堂| 亚洲国产精品999| 久久国内精品自在自线图片| 免费观看a级毛片全部| 国产淫语在线视频| av卡一久久| 国产极品天堂在线| av在线老鸭窝| av国产精品久久久久影院| 日韩欧美 国产精品| 高清毛片免费看| 久久久精品94久久精品| 成人亚洲欧美一区二区av| 天堂俺去俺来也www色官网| 黑人高潮一二区| 看免费成人av毛片| 丝袜脚勾引网站| 99久久精品热视频| 熟女av电影| 欧美 亚洲 国产 日韩一| 婷婷色综合大香蕉| 午夜视频国产福利| 精品久久久精品久久久| 国产 一区精品| videos熟女内射| 日本爱情动作片www.在线观看| 成人毛片a级毛片在线播放| 99热这里只有精品一区| 国产精品一区二区在线不卡| 成年美女黄网站色视频大全免费 | 亚洲成色77777| 青春草国产在线视频| 777米奇影视久久| 日韩熟女老妇一区二区性免费视频| 秋霞在线观看毛片| 大码成人一级视频| 少妇高潮的动态图| 少妇熟女欧美另类| 国产精品人妻久久久影院| 精品酒店卫生间| 国产乱来视频区| 日韩中文字幕视频在线看片| 精品酒店卫生间| a级毛色黄片| 啦啦啦在线观看免费高清www| 国产在线免费精品| 亚洲精品第二区| 亚洲自偷自拍三级| 国产黄片美女视频| 热re99久久精品国产66热6| 国产男女内射视频| 免费av不卡在线播放| 欧美3d第一页| 夫妻午夜视频| 你懂的网址亚洲精品在线观看| 女的被弄到高潮叫床怎么办| 亚洲精品国产色婷婷电影| 亚洲欧美精品自产自拍| 内地一区二区视频在线|